It has been reported that the mitogen activated protein kinase (MAPK) pathway may be involved in EA-induced cell death [17], but MAPK inhibitors are not generally cytotoxic to CLL cells. Here, WNK2 is linked to B-cell chronic lymphocytic leukemia.